Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_assertion type Assertion NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_head.
- NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_assertion description "[In tumor cells, PRL-3 mRNA levels varied markedly with high expression in SKNAS neuroblastoma, MCF-7 and BT474 breast carcinoma, Hep3B hepatocellular carcinoma, and HCT116 colon carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_provenance.
- NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_assertion evidence source_evidence_literature NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_provenance.
- NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_assertion SIO_000772 16505094 NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_provenance.
- NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_assertion wasDerivedFrom lhgdn-20090331 NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_provenance.
- NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_assertion wasGeneratedBy ECO_0000203 NP179387.RAj2lMZoSlR38rx6kdLLl3m_92NdsNBdr4w721HGxbpCU130_provenance.